NCT02784262View on ClinicalTrials.gov

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 4, 2018

Study Completion Date

December 31, 2018

Conditions
Chronic DiseaseNasal PolyposisRhinitis
Interventions
DRUG

botox injection Multiguide

botox injection under CT/MR navigation and with the navigation tool MultiGuide

Trial Locations (1)

Unknown

St Olavs Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER

NCT02784262 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis | Biotech Hunter | Biotech Hunter